Skip to main content

Table 1 Descriptive analysis of the eligible participants for injectable treatment in the prebupIV survey (n = 371 participants)

From: Willingness to receive intravenous buprenorphine treatment in opioid-dependent people refractory to oral opioid maintenance treatment: results from a community-based survey in France

  Questionnaire online (n = 95) Questionnaire face-to-face (n = 276) P-value Total (n = 371)
Gender    0.03  
 male 66 (72) 226 (82)   292 (80)
 female 26 (28) 48 (18)   74 (20)
Age – yearsa
Median [IQR] 31 [24; 40] 34 [29; 40] 0.02 33 [28; 40]
Stable housing    0.61  
 No 37 (39) 116 (42)   153 (42)
 Yes 57 (61) 158 (58)   215 (58)
Employment    0.02  
 No 53 (58) 196 (72)   249 (68)
 Yes 38 (42) 77 (28)   115 (32)
Opioid most injectedb    0.17  
 Morphine sulfate 14 (15) 50 (18)   64 (17)
 Heroin 21 (22) 35 (13)   56 (15)
 Buprenorphinec 52 (55) 164 (59)   216 (58)
 Other prescription opiatesd 8 (8) 27 (10)   35 (10)
Main reason for injecting    0.27  
 To get “high” 19 (20) 53 (27)   72 (24)
 To avoid withdrawal or to feel good enough for daily functioning 60 (65) 109 (55)   169 (58)
 Pleasure of the act 14 (15) 38 (19)   52 (18)
Cocaine useb    < 0.001  
 No 67 (72) 116 (42)   183 (50)
 Yes 26 (28) 157 (58)   183 (50)
Benzodiazepine useb    0.223  
 No 68 (73) 181 (66)   249 (68)
 Yes 25 (27) 92 (34)   117 (32)
Alcohol consumptionb    < 0.001  
 No 71 (75) 141 (51)   212 (57)
 Yes 24 (25) 135 (49)   159 (43)
Injection-related complications    0.84  
  ≤ 5 complications 81 (85) 233 (84)   314 (85)
  > 5 complications 14 (15) 43 (16)   57 (15)
History of overdose    0.89  
 No 74 (78) 213 (77)   287 (77)
 Yes 21 (22) 63 (23)   84 (23)
Currently on OMT    0.43  
 No 20 (21) 53 (19)   73 (20)
 Yes 75 (79) 223 (81)   298 (80)
Self-reported HCV status    0.020  
 No 70 (79) 170 (65)   240 (69)
 Yes 19 (21) 90 (35)   109 (31)
  1. IQR Interquartile range, OMT Opioid Maintenance Treatment
  2. ain years;
  3. bduring the previous 12 months;
  4. camong buprenorphine injectors: median [IQR] amounts (milligrams) injected per day = 12 [8–16] and median [IQR] numbers of injection per day = 3 [2–4]
  5. dmethadone, oxycodone, codeine and others